Antiplasmodial Biflavanones from the Stem Bark of Garcinia buchananii Engl

Show simple item record

dc.contributor.author Anyango Omole, Ruth
dc.contributor.author Julius Moshi, Mainen
dc.contributor.author Heydenreich, Matthias
dc.contributor.author Masanja Malebo, Hamisi
dc.contributor.author Waweru Gathirwa, Jeremiah
dc.contributor.author Owor Oriko, Richard
dc.contributor.author Kerubo Omosa, Leonida
dc.contributor.author Ogweno Midiwo, Jacob
dc.date.accessioned 2020-09-30T07:44:17Z
dc.date.available 2020-09-30T07:44:17Z
dc.date.issued 2019-07-09
dc.identifier.uri http://dspace.muhas.ac.tz:8080/xmlui/handle/123456789/2450
dc.description.abstract Introduction: Plants of the genus Garcinia are traditionally used treat a range of infectious and non-infectious diseases. Garcinia species are reported to have been shown to have a range of biological activities including cytotoxicity antimicrobial, antifungal, antioxidant, antimalarial and HIV-1 protease inhibitory activity among others. Methods: Solvent extraction was done using CH2Cl2: MeOH (1:1). Isolation was done using column chromatography with silica gel as the stationery phase and ethyl acetate and n-hexane used as mobile phase in increasing polarity. Thin layer chromatography was used to monitor the isolation. Structure elucidation was done using nuclear magnetic resonance and mass spectroscopic techniques. Chloroquine resistant (W2) and chloroquine sensitive (D6) P. falciparum strains were used for antiplasmodial assay. Results: Further bioassay guided fractionation of a CH2Cl2: MeOH (1:1) extract of Garcinia buchananii led to the isolation of two already reported biflavanones, isogarcinol (1) and guttiferone (2) with promising antiplasmodial activity against a chloroquine resistant (W2) Plasmodium falciparum strain with an IC50 of 2.8 ± 0.90 μg/mL for compound 1 and IC50 of 3.94 ± 0.38 μg/mL for compound 2. Compounds 1 and 2 also exhibited moderate activity against the chloroquine sensitive (D6) Plasmodium falciparum strain with IC50 of 7.03±0.60 and 10.64±4.50 μg/mL, respectively. Conclusion: The results provide proof to support the use of G. buchananii by the indigenous community for antimalarial therapy. en_US
dc.language.iso en en_US
dc.publisher Pharmacognosy Communications en_US
dc.relation.ispartofseries vol 9;No. 3
dc.subject Garcinia buchananii en_US
dc.subject Isogarcinol en_US
dc.subject Guttiferone en_US
dc.subject Antiplasmodial activity en_US
dc.title Antiplasmodial Biflavanones from the Stem Bark of Garcinia buchananii Engl en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search MUHAS IR


Advanced Search

Browse

My Account